Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens

Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens

US Patent 8182820 · Granted May 22, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for displaying a remote browser isolation (RBI) configuratio2024
Immunogenic compositions comprising FIV and HIV gag antigens2021
Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and c2021
Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and c2020
Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and c2018
Materials and methods for immunizing against FIV infection2014
Materials and methods for immunizing against FIV infection2010
Multi-subtype FIV vaccines2007
Multi-subtype FIV vaccines2007
Combination therapy for treatment of FIV infection2005
Combination therapy for treatment of FIV infection2005
Multi-subtype FIV vaccines2003